首页> 美国卫生研究院文献>Neuro-oncology Advances >RADI-33. DISTRIBUTED FRAMELESS GAMMA KNIFE RADIOSURGERY: A NEW TREATMENT PARADIGM FOR PATIENTS WITH BRAIN METASTASES
【2h】

RADI-33. DISTRIBUTED FRAMELESS GAMMA KNIFE RADIOSURGERY: A NEW TREATMENT PARADIGM FOR PATIENTS WITH BRAIN METASTASES

机译:拉迪33。分布式无框架伽玛刀放射外科:脑转移患者的新治疗方法

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

INTRODUCTION: Stereotactic radiosurgery (SRS) has excellent efficacy for patients with limited intracranial disease. Its use in patients with >10 brain metastases remains controversial. Nonetheless, cancer patients are living longer due to advancements in systemic therapeutics and avoiding the neurocognitive toxicities of whole brain radiation therapy is critical. Recent reports suggest that SRS may be effective in patients with ≥10 metastases. Treating large numbers of brain metastases in a single Gamma Knife radiosurgery (GKRS) treatment session poses several challenges. Treatment of metastases in close proximity to one another leads to an increased dose to normal brain, potentially increasing the risk of necrosis. Furthermore, single session treatment of multiple metastases may last several hours, causing significant patient discomfort. Here, we describe a novel treatment paradigm to address these issues: distributed frameless GKRS. Patients with ≥6 brain metastases undergo multi-session frameless GKRS with both temporal and spatial distribution over 2–5 sessions, decreasing treatment time per day and not treating adjacent metastases simultaneously. METHODS: We evaluated all patients with brain metastases who underwent distributed frameless SRS, using the Gamma Knife ICON, between January 2017 and November 2018. Fifty-one patients with 1097 unique lesions were included in this analysis. RESULTS: Mean patient age was 58.8 (range 29–89) years. Median follow-up was 4.1 (range: 0–20.4) months. The median number of metastases treated was 5 (range: 1–19) per treatment session and 11.5 (range: 3–82) per treatment course. The median number of treatment sessions per treatment course was 3 (range: 2–10). The median number of treatment courses, per patient, was 1 (range: 1–4). The median margin dose was 15 Gy. The median overall survival was 5.9 (range: 0.2–20.9) months. CONCLUSIONS: Distributed frameless Gamma Knife radiosurgery is technically feasible and should be considered in lieu of single session GKRS for patients with ≥6 brain metastases.
机译:简介:立体定向放射外科手术(SRS)对颅内疾病受限的患者具有出色的疗效。它在> 10例脑转移患者中的使用仍存在争议。尽管如此,由于全身疗法的进步,癌症患者的寿命更长,因此避免全脑放射疗法的神经认知毒性至关重要。最近的报道表明,SRS对转移≥10的患者可能有效。在单个伽玛刀放射外科(GKRS)治疗过程中治疗大量的脑转移瘤带来了许多挑战。彼此紧邻的转移治疗导致正常大脑的剂量增加,可能增加坏死的风险。此外,多次转移的单次治疗可能持续数小时,导致患者明显不适。在这里,我们描述一种新颖的治疗范例来解决这些问题:分布式无框架GKRS。 ≥6个脑转移的患者接受多疗程的无框架GKRS,在2-5个疗程中具有时空分布,每天减少治疗时间,并且不同时治疗相邻的转移瘤。方法:我们使用Gamma Knife ICON评估了2017年1月至2018年11月之间所有接受了分布式无框架SRS的脑转移患者。该分析包括51例具有1097个独特病变的患者。结果:平均患者年龄为58.8岁(范围29-89)。中位随访时间为4.1个月(范围:0–20.4)。每疗程转移的中位数目为5(范围:1–19),每个疗程为11.5(范围:3–82)。每个治疗疗程的中位治疗次数为3(范围:2-10)。每位患者的治疗疗程中位数为1(范围:1-4)。中位数保证剂量为15 Gy。中位总生存期为5.9(范围:0.2-20.9)个月。结论:分布式无框架伽玛刀放射外科手术在技术上是可行的,并且对于≥6脑转移的患者,应考虑使用单次GKRS代替。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号